Bruce Ogilvie, Executive Chairman of Alliance Entertainment, appears on the RedChip Small Stocks Big Money ™ show on Bloomberg TV to discuss Alliance Entertainment’s position at the center of the ...
Grade Purity, Third-Party Testing, and Mitochondrial Support Claims Are Reshaping Consumer Evaluation Standards for Methylene ...
Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving ...
Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
Southwest Research Institute has upgraded its nuclear magnetic resonance (NMR) laboratory to offer robust chemical analysis ...
North America leads the market due to widespread adoption of automated retail technologies and advanced payment systems.
Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...
Newron Pharmaceuticals expands IP portfolio for evenamide with new European Union composition of matter patent: Milan, Italy Thursday, January 8, 2026, 14:00 Hrs [IST] Newron Phar ...
Regeneron Pharmaceuticals Inc. stock reached a significant milestone, hitting a 52-week high of $795.88. This achievement underscores a positive trend for the biotechnology company, reflecting a ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback